Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO | InvestorPlace
Here's Why Teva Shares are Trending Higher Today
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
New York could get $524M under opioid settlements with Teva - ABC News
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva shares surge after announcing global opioid settlement
Israel's Teva gives upbeat outlook as restructuring proceeds | AP News
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
TEVA: Teva Pharmaceutical Industries Ltd - Stock Price, Quote and News - CNBC
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Teva, amid massive restructuring, closes in on $3B cost-cutting goal | Fierce Pharma
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Insilico collaborates with Teva on AI system | EurekAlert!
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Is Teva Pharma's Restructuring Plan Actually 'More Reasonable'? | Investor's Business Daily
